급성 로타바이러스 장염 소아에서 질환의 중증도와 로타바이러스 VP7 & VP4 유전형의 분포에 대한 연구
Distribution of Disease Severity and Group A Rotavirus Genotypes (VP7 & VP4) in Children with Acute Rotavirus Gastroenteritis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: We aimed to study the distribution of rotavirus genotypes (VP7 and VP4) and disease severity of rotavirus gastroenteritis prevalent in our community. Methods: Stool samples were collected from 156 children who were hospitalized with rotavirus gastroenteritis from December 2007 to June 2008. The disease severity of all patients was scored using the Vesikari scale. After extraction of ds-RNA of the rotavirus, cDNA synthesis using reverse transcription and polymerase chain reaction (RT-PCR) and multiplex PCR was performed. Following this, the final identification of genotypes was performed. Results: Of the 156 samples, VP7(G) and VP4(P) genotypes were identified in 147 (94.2%) and 140 (89.7%) samples, respectively. G1 (116 of 147 samples; 78.9%) and P[8] (137 of 140 samples; 97.9%) were the most prevalent, respectively. Of the 138 samples identified of combination types of VP7 and VP4, G1P[8] (111 samples; 80.4%) was the most prevalent. Other combination types varied with very low distribution rates. 9.4% of genotypes were not included in the new vaccines. The disease severity score was 11.8±3.3 (mean±2SD). The distribution of disease severity was mild or moderate in 37.8% and severe in 62.2% of patients. Conclusion: The most prevalent genotype combination of rotavirus was G1P[8] and genotypes not included in the vaccines represented 9.4% in our community. Disease severity distribution of hospitalized children with rotavirus gastroenteritis was higher in the severe than in the mild and moderate categories. (Korean J Pediatr Gastroenterol Nutr 2011; 14: 148∼154)
Abstract
Purpose: We aimed to study the distribution of rotavirus genotypes (VP7 and VP4) and disease severity of rotavirus gastroenteritis prevalent in our community. Methods: Stool samples were collected from 156 children who were hospitalized with rotavirus gastroenteritis from December 2007 to June 2008. The disease severity of all patients was scored using the Vesikari scale. After extraction of ds-RNA of the rotavirus, cDNA synthesis using reverse transcription and polymerase chain reaction (RT-PCR) and multiplex PCR was performed. Following this, the final identification of genotypes was performed. Results: Of the 156 samples, VP7(G) and VP4(P) genotypes were identified in 147 (94.2%) and 140 (89.7%) samples, respectively. G1 (116 of 147 samples; 78.9%) and P[8] (137 of 140 samples; 97.9%) were the most prevalent, respectively. Of the 138 samples identified of combination types of VP7 and VP4, G1P[8] (111 samples; 80.4%) was the most prevalent. Other combination types varied with very low distribution rates. 9.4% of genotypes were not included in the new vaccines. The disease severity score was 11.8±3.3 (mean±2SD). The distribution of disease severity was mild or moderate in 37.8% and severe in 62.2% of patients. Conclusion: The most prevalent genotype combination of rotavirus was G1P[8] and genotypes not included in the vaccines represented 9.4% in our community. Disease severity distribution of hospitalized children with rotavirus gastroenteritis was higher in the severe than in the mild and moderate categories. (Korean J Pediatr Gastroenterol Nutr 2011; 14: 148∼154)
참고문헌 (27)
- Murphy TV, "Intussusception among infants given an oral rotavirus vaccine", N Engl J Med, 344, pp.564~572 (2001)
- Vesikari T, "Efficacy of rix4414 live attenuated human rotavirus vaccine in finnish infants", Pediatr Infect Dis J, 23, pp.937~943 (2004)
- Clark HF, "Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants", J Pediatr, 144, pp.184~190 (2004)
- Ruiz-Palacios GM, "Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis", N Engl J Med, 354, pp.11~22 (2006)
- Vesikari T, "Safety and efficacy of a pentavalent human-bovine (wc3) reassortant rotavirus vaccine", N Engl J Med, 354, pp.23~33 (2006)
- Gentsch JR, "Serotype diversity and reassortment between human and animal rotavirus strains: Implications for rotavirus vaccine programs", J Infect Dis, 192(1), pp.146~159 (2005)
- Santos N, "Global distribution of rotavirus serotypes", genotypes and its implication for the development and implementation of an effective rotavirus vaccine, 2005, pp.15, 29~56
- Kim DS, "Immunogenicity and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy infants in Korea", PEDIATRIC INFECTIOUS DISEASE JOURNAL, 27, pp.177~178 (2008), Pediatric Infectious Diseases Society
- Ruuska T, "Rotavirus disease in finnish children: Use of numerical scores for clinical severity of diarrhoeal episodes", Scand J Infect Dis, 22, pp.259~267 (1990)
- Gouvea V, "Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens", J Clin Microbiol, 28, pp.276~282 (1990)
- Gentsch JR, "Identification of group a rotavirus gene 4 types by polymerase chain reaction", J Clin Microbiol, 30, pp.1365~1373 (1992)
- Givon-Lavi N, "Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children", Vaccine, 26, pp.5798~5801 (2008)
- Sugata K, "Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis", Pediatrics, 122, pp.392~397 (2008)
- Aupiais C, "Severity of acute gastroenteritis in infants infected by g1 or g9 rotaviruses", J Clin Virol, 46, pp.282~285 (2009)
- Linhares AC, "Rotavirus serotype G9 is associated with more-severe disease in Latin America", Clin Infect Dis, 43, pp.312~314 (2006)
- Mast TC, "Burden of childhood rotavirus disease on health systems in the united states", Pediatr Infect Dis J, 29, pp.19~25 (2010)
- Iturriza-Gomara M, "Rotavirus surveillance in europe, 2005-2008: Web-enabled reporting and real-time analysis of genotyping and epidemiological data", J Infect Dis, 200(1), pp.215~221 (2009)
- Payne DC, "Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States", Pediatrics, 122, pp.1235~1243 (2008)
- in South Korea, "Journal of Medical Virology", 200801, 175~182, pp.Wiley-Liss Inc.
- Han T, "Genetic characterization of rotavirus in children in South Korea from 2007 to 2009", Arch Virol, 155, pp.1663~1673 (2010)
- Bishop R, "Discovery of rotavirus: implications for child health", J Gastroenterol Hepatol, 24(3), pp.81~85 (2009)
- Dey SK, "Seasonal trend and serotype distribution of rotavirus infection in Japan, 1981-2008", Pediatr Infect Dis J, 29, pp.166~167 (2010)
- 강기수, "제주지역에서 최근 수년간 관찰된 Rotavirus 위장관염의 발생 양상", Pediatric Gastroenterology, Hepatology & Nutrition, 8(2), pp.113~116 (2005), 대한소아소화기영양학회
- 양혜란, "급성 위장관염에 병발하는 양성 무열성 경련 소아 환자의 대변에서 검출된 바이러스 및 유전자형 분석 연구", Pediatric Gastroenterology, Hepatology & Nutrition, 12(2), pp.183~193 (2009), 대한소아소화기영양회
- 최재형, "신경학적 이상이 동반된 로타바이러스 위장관염 환아에서의 로타바이러스 유전형", Korean Journal of Pediatrics, 49(5), pp.513~518 (2006), 대한소아과학회
- Gleizes O, "Nosocomial rotavirus infection in european countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease", Pediatr Infect Dis J, 25, pp.12~21 (2006)
- Jung Oak Kang, "G and P Genotyping of Human Rotavirus Isolated in a University Hospital in Korea: Implications for Nosocomial Infections", Journal of Korean Medical Science, 21(6), pp.983~988 (2006), 대한의학회